呈现CD24 ScFv的基因平台通过恢复巨细胞化和调节免疫环境来增强抗瘤免疫力

Guannan Zhou1, Yuanyuan Gu2, Menglei Zhang2

  • 1Shanghai Key Lab of Reproduction and Development, Shanghai Key Lab of Female Reproductive Endocrine Related Diseases, Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200433, China. zgnsmmu@163.com.

概括

研究人员开发了CD24单链可变片段工程外细胞囊泡 (CD24 scFv-EVs),以准CD24过度表达的卵巢和乳腺癌. 这种免疫疗法方法增强了巨细胞化,促进了癌细胞清除和M1样两极分化.